20.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen20.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen20.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen20.04.24 | Vollzeit | Tübingen | Immatics Biotechnologies GmbHImmatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies
Später ansehen20.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen17.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHYears of expertise in researching, developing and optimizing the versatile biological molecule for medical purposes. Our focus is on prophylactic vaccines, innovative cancer immunotherapies, and protein-based therapies. All RNA people are striving to achieve our main joint goal To bring multiple best
Später ansehen12.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen16.04.24 | Vollzeit | Tübingen | Immatics Biotechnologies GmbHImmatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies
Später ansehen28.03.24 | Vollzeit | Tübingen | Fraunhofer-Institut für Arbeitswirtschaft und Organisation IAODie Fraunhofer-Gesellschaft betreibt in Deutschland derzeit 76 Institute und Forschungseinrichtungen und ist die weltweit führende Organisation für anwendungsorientierte Forschung. Rund 30 800 Mitarbeitende erarbeiten das jährliche Forschungsvolumen von 3,0 Milliarden Euro. Die Teams unseres Bereich
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für System Developer in Tübingen kostenlos abonnieren.